Related Experiment Video
Updated: May 15, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
[Current status and progress of fungal endophthalmitis treatment]
1Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Abstract:
Fungal endophthalmitis is a devastating infectious disease, with a poor visual prognosis and even possibility of eyeball enucleated. In recent years, the incidence of fungal endophthalmitis remarkably increased due to widely use of broad-spectrum antibiotics and corticosteroid hormone. This pose a challenge to ophthalmologists and their capacity of treating fungal endophthalmitis need to be improved. It is necessary to introduce the present status and progress in fungal endophthalmitis treatment focus on medications, surgery and its etiological examination, especially the use of newer antifungal agents, including voriconazole and liposomal amphotericin B.
Insights
Fungal endophthalmitis, an eye infection, is increasing due to antibiotic and steroid use. Treatment advances, including new antifungal drugs, offer improved outcomes for this serious condition.
Area of Science:
- Ophthalmology
- Mycology
- Infectious Diseases
Context:
- Fungal endophthalmitis incidence is rising, posing challenges for ophthalmologists.
- Widespread use of broad-spectrum antibiotics and corticosteroids contributes to increased fungal infections.
- Poor visual prognosis and risk of eyeball enucleation highlight the severity of this condition.
Purpose:
- To review current treatment strategies for fungal endophthalmitis.
- To highlight advancements in medications, surgical interventions, and etiological examination.
- To emphasize the role of newer antifungal agents like voriconazole and liposomal amphotericin B.
Summary:
- Fungal endophthalmitis is a severe intraocular infection with increasing incidence.
- Treatment involves medications, surgery, and etiological diagnosis.
- Emerging antifungal therapies, including voriconazole and liposomal amphotericin B, are crucial for management.
Impact:
- Improved understanding of fungal endophthalmitis treatment options.
- Enhanced clinical capacity for managing this challenging ophthalmic condition.
- Potential for better visual prognoses through timely and appropriate interventions.
Related Concept Videos
Endocarditis III: Medical Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Endocarditis IV: Nursing Management